MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 15.5

Change

+0.00 (+0.03)%

Market Cap

USD 0.48B

Volume

2.63K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.71 (-1.55%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.60 (-0.30%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.99 (-0.26%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

-0.12 (-0.35%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.43 (-0.17%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.80 (+0.17%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.02 (-0.30%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.02 (-0.30%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.16 (-0.29%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.59 (-0.70%)

USD 5.38B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.52% 93% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.52% 93% A 80% B-
Trailing 12 Months  
Capital Gain 10.26% 77% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.26% 75% C 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.79% 61% D- 67% D+
Dividend Return 9.79% 60% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.79% 75% C 87% B+
Risk Adjusted Return 125.67% 95% A 97% N/A
Market Capitalization 0.48B 63% D 68% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike